Assembly Biosciences, Inc. (ASMB) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Assembly Biosciences, Inc. (ASMB) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

ASMB Income Statement

Assembly Biosciences, Inc. (ASMB) annual income statement — 18-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	13.37M	8.21M	42.47M	10.79M	9.63M	9.42M	7.36M	6.84M	8.53M	5.79M	7.16M	0	0	0	0	0	0	0	0	6.25M
Revenue Growth %	38.94%	-12.8%	477.26%	57.62%	12.81%	62.82%	2.71%	-	-	-	-	-	-	-	-	-100%	-	-	-100%	-81.93%
Cost of Goods Sold	20K	26K	32K	16.59M	16.13M	14.85M	14.28M	13.52M	32K	32K	84K	10.82M	12.52M	14.55M	17.25M	17.43M	17.29M	17.2M	12.27M	18.47M
COGS % of Revenue	0.15%	0.32%	0.08%	153.74%	167.52%	157.67%	194.1%	197.44%	0.38%	0.55%	1.17%	-	-	-	-	-	-	-	-	295.39%
Gross Profit	13.35M	8.19M	42.44M	-5.8M	-6.5M	-5.43M	-6.92M	-6.67M	8.5M	5.75M	7.08M	-10.82M	-12.52M	-14.55M	-17.25M	-17.43M	-17.29M	-17.2M	-12.27M	-12.22M
Gross Margin %	99.85%	99.68%	99.92%	-53.74%	-67.52%	-57.67%	-94.1%	-97.44%	99.63%	99.45%	98.83%	-	-	-	-	-	-	-	-	-195.39%
Gross Profit Growth %	305.48%	250.72%	712.99%	13.07%	-176.45%	-194.42%	-197.8%	38.38%	167.88%	139.55%	141.03%	37.9%	27.58%	15.45%	-40.59%	-42.63%	-3.24%	7.27%	54.52%	-259.32%
Operating Expenses	19.7M	19.58M	22.67M	5.08M	4.59M	4.51M	4.61M	4.29M	20.7M	16.48M	19.63M	4.22M	4.96M	5.01M	5.72M	5.97M	7.28M	5.96M	50.62M	6.66M
OpEx % of Revenue	147.29%	238.44%	53.38%	47.13%	47.72%	47.87%	62.65%	62.61%	242.63%	284.91%	274.05%	-	-	-	-	-	-	-	-	106.41%
Selling, General & Admin	4.8M	4.68M	5.42M	5.08M	4.59M	4.51M	4.61M	4.29M	4.45M	4.6M	8.62M	4.22M	4.96M	5.01M	6.42M	5.17M	6.28M	5.96M	6.23M	6.66M
SG&A % of Revenue	35.9%	57.02%	12.76%	47.13%	47.72%	47.87%	62.65%	62.61%	52.09%	79.57%	120.4%	-	-	-	-	-	-	-	-	106.41%
Research & Development	14.92M	14.9M	17.25M	16.59M	16.13M	14.85M	14.28M	13.52M	16.26M	11.88M	11.01M	10.82M	12.52M	14.55M	16.85M	18.13M	17.79M	17.2M	14.75M	18.47M
R&D % of Revenue	111.54%	181.42%	40.62%	153.74%	167.52%	157.67%	194.1%	197.44%	190.54%	205.34%	153.65%	-	-	-	-	-	-	-	-	295.39%
Other Operating Expenses	-20K	0	0	-1000K	-1000K	-1000K	-1000K	-1000K	0	0	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	1000K	-1000K
Operating Income	-6.34M	-11.37M	19.8M	-10.88M	-11.09M	-9.94M	-11.53M	-10.96M	-12.2M	-10.73M	-12.55M	-15.05M	-17.49M	-19.56M	-22.98M	-23.4M	-24.57M	-23.16M	-62.89M	-18.88M
Operating Margin %	-47.44%	-138.44%	46.62%	-100.87%	-115.24%	-105.54%	-156.75%	-160.06%	-143.01%	-185.46%	-175.22%	-	-	-	-	-	-	-	-	-301.81%
Operating Income Growth %	42.81%	-14.37%	271.69%	0.67%	9.1%	7.34%	8.12%	27.19%	30.22%	45.15%	45.38%	35.7%	28.83%	15.56%	63.46%	-23.98%	-3.83%	15.03%	-58.64%	-369.64%
EBITDA	-6.32M	-11.34M	19.83M	-10.85M	-11.06M	-9.91M	-11.5M	-10.92M	-12.17M	-10.7M	-12.47M	-14.93M	-17.36M	-19.43M	-22.85M	-23.27M	-24.45M	-23.04M	-62.77M	-18.76M
EBITDA Margin %	-47.29%	-138.12%	46.7%	-100.57%	-114.91%	-105.19%	-156.31%	-159.58%	-142.63%	-184.91%	-174.05%	-	-	-	-	-	-	-	-	-299.9%
EBITDA Growth %	42.83%	-14.49%	272.44%	0.66%	9.12%	7.38%	7.76%	26.85%	29.9%	44.96%	45.45%	35.82%	29%	15.65%	63.59%	-24.05%	-3.85%	15.13%	-59.6%	-383.53%
D&A (Non-Cash Add-back)	20K	26K	32K	32K	32K	33K	32K	33K	32K	32K	84K	116K	126K	124K	124K	134K	120K	120K	120K	119K
EBIT	-3.86M	-9.08M	22.09M	-9.2M	-10.2M	-8.82M	-10.26M	-9.61M	-10.75M	-9.08M	-10.93M	-15.05M	-17.49M	-19.56M	-23.68M	-22.6M	-23.57M	-23.16M	-18.5M	-18.88M
Net Interest Income	2.49M	2.29M	2.29M	1.69M	895K	1.12M	1.12M	1.34M	1.46M	1.65M	1.62M	628K	592K	609K	583K	256K	112K	71K	101K	72K
Interest Income	2.49M	2.29M	2.29M	1.69M	895K	1.12M	1.12M	1.34M	1.46M	1.65M	1.62M	628K	592K	609K	583K	256K	112K	71K	101K	72K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	2.49M	2.29M	2.29M	1.69M	895K	1.12M	1.27M	1.34M	1.46M	1.65M	1.62M	628K	592K	609K	583K	256K	112K	71K	101K	72K
Pretax Income	-3.86M	-9.08M	22.09M	-9.2M	-10.2M	-8.82M	-10.26M	-9.61M	-10.75M	-9.08M	-10.93M	-14.42M	-16.9M	-18.95M	-22.39M	-23.14M	-24.46M	-23.09M	-62.79M	-18.8M
Pretax Margin %	-28.84%	-110.54%	52.01%	-85.23%	-105.94%	-93.62%	-139.45%	-140.44%	-125.93%	-156.91%	-152.58%	-	-	-	-	-	-	-	-	-300.66%
Income Tax	0	0	0	0	0	0	76K	0	406K	0	33K	0	0	0	0	0	0	0	-2.53M	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	-0.74%	0%	-3.78%	0%	-0.3%	0%	0%	0%	0%	0%	0%	0%	4.03%	0%
Net Income	-3.86M	-9.08M	22.09M	-9.2M	-10.2M	-8.82M	-10.34M	-9.61M	-11.15M	-9.08M	-10.96M	-14.42M	-16.9M	-18.95M	-22.39M	-23.14M	-24.46M	-23.09M	-60.26M	-18.8M
Net Margin %	-28.84%	-110.54%	52.01%	-85.23%	-105.94%	-93.62%	-140.48%	-140.44%	-130.69%	-156.91%	-153.04%	-	-	-	-	-	-	-	-	-300.66%
Net Income Growth %	62.18%	-2.96%	313.74%	4.34%	8.55%	2.85%	5.72%	33.34%	34%	52.1%	51.05%	37.7%	30.93%	17.93%	62.83%	-23.09%	-3.67%	15.11%	-52.87%	-461.45%
Net Income (Continuing)	-3.86M	-9.08M	22.09M	-9.2M	-10.2M	-8.82M	-10.34M	-9.61M	-11.15M	-9.08M	-10.96M	-14.42M	-16.9M	-18.95M	-22.39M	-23.14M	-24.46M	-23.09M	-60.26M	-18.8M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.20	-0.54	2.49	-1.20	-1.33	-1.17	-1.72	-1.51	-1.98	-1.66	-2.00	-3.29	-3.88	-4.31	-5.32	-4.70	-5.00	-4.80	-13.20	-4.10
EPS Growth %	84.96%	53.85%	244.77%	20.53%	32.83%	29.52%	14%	54.1%	48.97%	61.48%	62.41%	30%	22.4%	10.21%	59.7%	-14.63%	9.09%	30.43%	-57.95%	-334.78%
EPS (Basic)	-0.20	-0.54	2.49	-1.20	-1.33	-1.17	-1.72	-1.51	-1.98	-1.66	-2.00	-3.29	-3.88	-4.31	-5.32	-4.70	-5.00	-4.80	-13.40	-4.10
Diluted Shares Outstanding	18.85M	16.9M	11.21M	7.66M	7.66M	7.51M	6.58M	6.35M	5.64M	5.48M	5.48M	4.38M	4.36M	4.25M	4.07M	4.84M	4.83M	4.81M	4.56M	4.56M
Basic Shares Outstanding	18.85M	16.9M	11.21M	7.66M	7.66M	7.51M	6.58M	6.35M	5.64M	5.48M	5.48M	4.38M	4.36M	4.25M	4.07M	4.84M	4.83M	4.81M	4.49M	4.56M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-